ZofranLegal.com provided details of another lawsuit filed against GlaxoSmithKline regarding their anti-nausea drug Zofran. This suit, filed by parents from San Francisco, California under case number CGC-15-544524, alleged that because the mother had used Zofran while pregnant, her child was born with a severe congenital heart defect known as Bicuspid Aortic Stenosis.
The suit was filed on March 5th of 2015 in the Superior Court for the State of California in San Francisco. Documents indicate that the plaintiff’s son was born in 2009 and immediately diagnosed with his congenital heart defect. She had been prescribed Zofran to combat her morning sickness, and began using the drug early in her pregnancy, while her baby was developing in utero. The boy’s parents have no familial history of birth defects, and were unaware of any potential risks caused by Zofran.
At this time, the family seeks compensation for medical expenses so that they are able to monitor their son’s heart and also provide future necessary surgeries to properly repair his aortic valve. The boy’s condition, Bicuspid Aortic Stenosis (BAV) develops during the first trimester of pregnancy when the heart is forming, and occurs when two aortic valvular leaflets fuse together, creating a bicuspid valve rather than a tricuspid valve. Heart murmurs can indicate this condition.
Stenosis happens within the heart as well as calcium deposits accumulate around the leaflets and make them more stiff. This means that the heart has to work harder to pump out blood. In serious cases of BAV, heart failure is possible, and immediate surgery is required.
Ms. Elizabeth Graham, a team member at ZofranLegal.com, is helping to represent the plaintiff in this case along with another law firm. Currently, lawsuits continue to appear across the U.S. and number over 60. This number is expected to continue to rise. Individuals who have used Zofran while pregnant and have subsequently given birth to a child with defects may be entitled to compensation.
The attorneys at Monheit Law are currently working to provide free consultation for anyone who would like to look into their legal options concerning this matter. For more information on this subject, or to ask questions, please contact Attorney Michael Monheit by calling 877-620-8411.
Sponsored by an alliance of attorneys, ZofranLegal.com is a resource for parents, families and birth defect survivors interested in learning more about litigation surrounding the nausea drug Zofran and its link to increased risks of major birth defects.
1368 Barrowdale Road, Rydal, PA 19046
April 30, 2016 – Lawsuit Alleges Invokana Side Effects Can Include Diabetic Ketoacidosis, a Life-Threatening Condition Related to Too Much Acid in the Body
April 29, 2016 – Zofran Lawsuit Update: Plaintiffs Question Why GSK Hasn’t Faced Stiffer Penalties
April 27, 2016 – Arkansas Mother Files Zofran Lawsuit Claiming Multiple Defects Caused By Drug
April 25, 2016 – Zofran Lawsuit Plaintiffs Applaud FDA’s Decision Regarding Folic Acid
April 22, 2016 – MyFoxBoston News Release Discusses Concerning Zofran Birth Defect Lawsuits And Drug Safety
April 22, 2016 – Zofran Lawsuit Plaintiffs Note Results Of Japanese Animal Studies Linking Birth Defects To Drug
April 22, 2016 – A Look Back At America’s First Zofran Lawsuit
April 21, 2016 – Significant Increase In Birth Defect Development Investigated By Washington State Amid Mounting Zofran Lawsuits
April 21, 2016 – Zofran Lawsuit Plaintiffs Make Note Of Canadian Label Differences On Drug Which Warn Of Use During Pregnancy
April 20, 2016 – Zofran Lawsuit Plaintiff Claims Infant’s Cleft Palate, Clubfoot, And Respiratory Distress Caused By Drug Exposure
